TY  - GEN
AU  - Pepe,Martino
AU  - Cafaro,Alessandro
AU  - Paradies,Valeria
AU  - Signore,Nicola
AU  - Addabbo,Francesco
AU  - Bortone,Alessandro Santo
AU  - Navarese,Eliano Pio
AU  - Contegiacomo,Gaetano
AU  - Forleo,Cinzia
AU  - Bartolomucci,Francesco
AU  - Di Cillo,Ottavio
AU  - Bianchi,Francesco Paolo
AU  - Zanna,Domenico
AU  - Favale,Stefano
TI  - Time-dependent benefits of pre-treatment with new oral P2Y
SN  - 1522-726X
PY  - 2020///0414
KW  - Administration, Oral
KW  - Aged
KW  - Blood Platelets
KW  - drug effects
KW  - Coronary Angiography
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Percutaneous Coronary Intervention
KW  - adverse effects
KW  - Platelet Aggregation Inhibitors
KW  - administration & dosage
KW  - Prasugrel Hydrochloride
KW  - Purinergic P2Y Receptor Antagonists
KW  - Receptors, Purinergic P2Y12
KW  - blood
KW  - Risk Assessment
KW  - Risk Factors
KW  - ST Elevation Myocardial Infarction
KW  - diagnostic imaging
KW  - Ticagrelor
KW  - Time Factors
KW  - Time-to-Treatment
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Observational Study
UR  - https://doi.org/10.1002/ccd.27863
ER  -